Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Post-operative Residual Curarization × Sugammadex × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 2 Urologic Neoplasms 1 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Post-operative Residual Curarization 1 Neuromuscular Blockade 1 Endobronchial Metastases 1 Emergence Delirium 1

Interventions

Sugammadex 1 Neostigmine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03996655 2019-06-25

Different Reversal Agents in Pediatric Day-case Cancer Surgery

National Cancer Institute, Egypt

Phase 4 Unknown

Post-operative Residual Curarization

Data powered by HemOnc (CC BY 4.0) Colophon ⚡